Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00940004
Recruitment Status : Completed
First Posted : July 15, 2009
Last Update Posted : April 17, 2017
Information provided by (Responsible Party):
Radboud University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2014
  Study Completion Date : November 2014